MwanzoJNJ • NYSE
add
Johnson & Johnson
$ 160.13
Baada ya Saa za Kazi:(0.053%)-0.084
$ 160.05
Imefungwa: 1 Nov, 17:36:28 GMT -5 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 159.86
Bei za siku
$ 159.88 - $ 161.06
Bei za mwaka
$ 143.13 - $ 168.85
Thamani ya kampuni katika soko
385.53B USD
Wastani wa hisa zilizouzwa
6.02M
Uwiano wa bei na mapato
26.47
Mgao wa faida
3.10%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 22.47B | 5.25% |
Matumizi ya uendeshaji wa biashara | 10.20B | 18.80% |
Mapato halisi | 2.69B | -89.65% |
Kiwango cha faida halisi | 11.99 | -90.16% |
Mapato kwa kila hisa | 2.42 | -9.02% |
EBITDA | 7.36B | -10.41% |
Asilimia ya kodi ya mapato | 19.29% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 20.30B | -13.67% |
Jumla ya mali | 178.29B | 7.36% |
Jumla ya dhima | 108.13B | 14.02% |
Jumla ya hisa | 70.16B | — |
hisa zilizosalia | 2.41B | — |
Uwiano wa bei na thamani | 5.49 | — |
Faida inayotokana na mali | 7.66% | — |
Faida inayotokana mtaji | 12.58% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.69B | -89.65% |
Pesa kutokana na shughuli | 7.99B | — |
Pesa kutokana na uwekezaji | -3.13B | — |
Pesa kutokana na ufadhili | -9.88B | — |
Mabadiliko halisi ya pesa taslimu | -4.90B | — |
Mtiririko huru wa pesa | 5.50B | — |
Kuhusu
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
Jan 1886
Makao Makuu
Tovuti
Wafanyakazi
131,900
